This is especially important at higher doses where you are injecting larger volumes
Week 14 begins at 0.25 mg weekly, then increases to 0.5 mg for weeks 58, followed by 1.0 mg for weeks 912, and continuing upward by 0.25 mg increments every 4 weeks until your provider determines your therapeutic target
As GLP-1 use rises, WashU trial examines real-life impacts for patients ST
To assess the potential effects of ATP released from L-cells on surrounding enterocytes and the regulation of colonic mucosal functions we utilised Ussing chambers and measured the short-circuit current ( I sc ) as a marker of electrogenic ion transport across the colonic epithelium
EASD, European Association for the Study of Diabetes
Researchers use IGF-1 LR3 to analyze cell-signaling behavior, pathway activation, and assay response profiles